We analyzed an outbreak of Escherichia coli bacteremia in eight patients with leukemia in a hematology-oncology unit from July to September 1994. The antibiograms and genotypic patterns of the isolates were different, thus suggesting that the outbreak did not originate from a single clone. However, all the isolates were resistant to quinolones, which led us to examine the microbiological records from 1992 to 1994. The incidence of quinolone-resistant E. coli bacteremia in the hematology-oncology unit ranged from 81.8% to 94.6% during this period. We then analyzed 36 more isolates recovered from late 1994 to 1995. Field inversion gel electrophoresis patterns of these isolates were also different. Analysis of the quinolone resistance determining region in gyrA revealed that all the isolates had a double mutation in gyrA. In conclusion, quinolone-resistant E. coli could be an emerging threat to neutropenic patients with leukemia who receive a quinolone prophylactically, and attention must be paid to this trend of resistance.
Quinolones are potent antimicrobial agents used for treathas an eight-bed bone marrow transplantation center and a hematooncology unit with eight isolation rooms and 32 inpament of infection caused by gram-negative organisms [1] . These agents are also useful for prophylactic gut decontaminatient rooms. Of the eight cases of E. coli bacteremia, four (cases 1, 3, 7, and 8) occurred in the same room, and two (cases 2 tion in patients with neutropenia [2] . Along with the increased use of quinolones, there have been many reports on the increasand 6) were in adjacent rooms. Surveillance cultures were done at that time, and samples were obtained from water sources, ing incidence of quinolone resistance in Staphylococcus aureus and Pseudomonas aeruginosa, but resistance in members of patients' stools, and health care workers' hands. the family Enterobacteriaceae, especially Escherichia coli, has been extremely rare until recently [1] . However, some investi-
Patients and Bacteria
gators have reported the emergence of quinolone resistance in E. coli isolated from patients with malignancies who received Eight cases of E. coli bacteremia were identified from July fluoroquinolone prophylaxis [3 -5] .
to September 1994. All the E. coli isolates from blood were Between July and September 1994, we recognized an unusually used for genotyping. From October 1994 to September 1995, frequent occurrence of E. coli bacteremia in eight patients with we collected 36 more blood isolates of E. coli to analyze the leukemia in a hematology-oncology unit. To discriminate the clonal relationship and quinolone resistance. strain-to-strain relatedness, we examined the genotypic patterns of these eight isolates. We also found that all of these isolates Plasmid Typing were resistant to ciprofloxacin; this finding led us to review the data on the antibiotic susceptibility patterns of E. coli isolated
Plasmid from E. coli isolates was extracted by an alkaline from 1992 to 1995 to investigate whether there were more cases lysis method [6] , and electrophoresis through 0.9% agarose of bacteremia due to quinolone-resistant E. coli. Since this outgels was performed. The gels were stained with ethidium brobreak, we have collected more isolates of E. coli and analyzed mide and inspected by ultraviolet translumination (320 nm). their genotypic patterns and mechanisms of resistance.
Materials and Methods

Field Inversion Gel Electrophoresis (FIGE) Clinical Setting
Isolates of E. coli were suspended on Mueller-Hinton broth St. Mary's Hospital is a tertiary care teaching hospital in at 37ЊC. After incubation overnight, the bacterial cells were Seoul, Korea, that serves a diverse patient population. It also centrifuged and washed twice. with an initial denaturing step at 95ЊC for 7 minutes; thereafter, the denaturing step was 30 cycles at 95ЊC for 1 minute, 55ЊC The plugs were then washed in 5 mL of each of the following washing solutions at 37ЊC for 16 hours with gentle shaking: for 1 minute, and 72ЊC for 2 minutes. The final extension step was done at 72ЊC for 5 minutes. 10 mM Tris-HCl (pH, 8.0), 1 mM EDTA (pH, 8.0), and 1 mM phenylmethylsulfonyl fluoride. For restriction endonuclease diPurification of PCR products was done by the addition of 100 mL of chloroform:isoamyl alcohol (24:1) and centrifugagestion, the plugs were cut into 0.2-cm slices and equilibrated with 100 mL of restriction buffer at 4ЊC for 30 minutes, and tion at 10,000g for 5 minutes. After centrifugation, 70 mL of the upper aqueous layer was transferred to a 0.5-mL microcenthen the slices were supplemented with 8 U of XbaI (Boehringer Mannheim, Mannheim, Germany) and incubated at 37ЊC for 6 trifuge tube and was stored at 020ЊC. Two microliters of purified PCR product were reacted with 8 U of HinfI at 37ЊC for hours. After digestion, the slices were loaded into the gel, and FIGE was performed. The conditions of FIGE were as follows:
2 hours. The reaction mixture was loaded on 3% multipurpose agarose (Boehringer Mannheim), and gel electrophoresis was the run-in time, 10 minutes; switch interval, 1 -25 seconds; forward-to-reverse ratio, 3:1; temperature of running solution, performed in 1 1 TAE at 4.2 V/cm for 1 hour. The RFLP pattern was visualized under ultraviolet light after staining with 14ЊC; and total running time, 18 hours [7] . The gels were stained with ethidium bromide, and the band patterns were ethidium bromide for 30 minutes; 0.4 mg of a 100-bp DNA ladder (GIBCO BRL, Burlington, Ontario, Canada) were used observed under ultraviolet translumination. If there was more than a seven-band difference, the strains were regarded as clonas the size marker. ally nonrelated [8] .
Single-Stranded Confirmation Polymorphism (SSCP) Analysis
The SSCP analysis was done by a heat denaturation method Determination of MICs [11] . Aliquots of 1 mL of PCR products were mixed with The susceptibility of the eight E. coli isolates to ciprofloxacin 1 mL of denaturant solution (90% formamide, 10 mM EDTA, (Pfizer Korea, Seoul, Korea) was examined by an agar dilution 0.05% bromophenol blue, 0.05% xylene cyanol); the mixture method. A strain was regarded as quinolone resistant if the was heated at 95ЊC for 5 minutes and then immediately cooled MIC of ciprofloxacin was ú4 mg/mL [9] . on ice. The denatured mixture was briefly centrifuged before use. The single-stranded PCR products were then separated by polyacrylamide gel (6.5% thymidine; 2.7% cytidine) electro-
Retrospective Review of Data from 1992 to 1995
phoresis at 15ЊC in 0.5 1 tris-borate EDTA at a constant voltWe investigated and searched all the microbiological literaage of 100 V for 16 hours. After electrophoresis, the gel was ture on E. coli bacteremia from 1992 to 1995, when the data placed in a fixative enhancer solution containing 200 mL of on microbiological records were computerized. All the data methanol (50% v/v), 40 mL of acetic acid (10% v/v), 40 mL were grouped into leukemia and nonleukemia cases, and the of fixative enhancer concentrate (10% v/v), and 120 mL of incidence of quinolone resistance determined by the disk diffudeionized distilled water for 20 minutes with gentle agitation. sion method was calculated for each group.
The staining procedure was then done with use of the silver stain plus kit (Bio-Rad, Richmond, CA). The gel was rinsed two times for 10 minutes and was stained in 100 mL of staining of reduction modulator solution, 5 mL of image development reagent, and 50 mL of room-temperature development accelera-A 684-bp gyrA fragment from an E. coli strain was amplified.
tor solution for 20 minutes. The staining reaction was stopped DNA was subjected to PCR analysis with use of 20-mer and by placing the gel in a 5% acetic acid solution. After rinsing 23-mer oligonucleotide primers (5-TAC ACC GGT CAA for 5 minutes and drying, DNA bands were visualized. CAT TGA GG-3 and 5-CCG GTA CGG TAA GCT TCT TCA AT-3, respectively), the sequences of which are identical [10] ; the QRDR (nucleotides 166 to 355; total size, 190 bp) is included in these positions. The whole procedure was performed with use of the Sequenase PCR product sequencing kit (USB, Amersham Life Science, Cleveland). Two microliters of a 333-bp PCR product was pretreated by reacting it with 10 U of exonuclease I/mL and 2.0 U of shrimp alkaline phosphatase/mL at 37ЊC for 15 minutes and then at 80ЊC for 15 minutes. The treated PCR product was annealed with the first primer and was denatured by heating for 3 minutes at 100ЊC.
Ten microliters of the annealed mixture was added to a labeling solution containing 0.1 M dithiothreitol, [ profloxacin (500 mg/d) and fluconazole (50 mg twice daily) was given to all patients for selective decontamination of the Although the antibiograms were different from each other, gastrointestinal tract. Only one patient died of intractable pneuall the isolates were resistant to ofloxacin and ciprofloxacin. monia (case 8). Surveillance cultures were negative for E. coli
The MICs for all the isolates were ú128 mg/mL. Therefore, (data not shown).
we retrospectively investigated data on E. coli bacteremia from 1992 to 1995. Surprisingly, there had been a high incidence of bacteremia due to quinolone-resistant E. coli since 1992. In
Genotypic Analysis
1992, the incidence of bacteremia due to ciprofloxacin-resistant When the switch interval was set to the range of 1 -25 sec-E. coli in patients with and without leukemia was 81.8% and onds, the patterns in lanes 1, 3, and 5 and lanes 2, 4, and 6 were 5.9%, respectively. Since then, the incidence steadily increased similar in the 100-to 500-kbp area ( figure 1A ). To enhance the among patients with leukemia: 89.4% in 1993, 94.6% in 1994, migration distance in this area, we shortened the switch interval and 92.9% in 1995 (table 1) . However, most of the quinoloneto 15 seconds and performed FIGE again [7] . Compared with resistant E. coli strains had a low rate of resistance to the the pattern in lane 1, those in lanes 3 and 5 had a difference empirical antimicrobial agents (e.g., amikacin, sulbactam, and of five to six fragments. The pattern in lane 5 also had a aztreonam) that were used as therapy for neutropenic patients difference of four fragments compared with that in lane 3.
with hematologic diseases in our hospital (table 2) . Compared with the pattern in lane 2, both those in lanes 4 and 6 had a difference of more than seven fragments (figure 1B).
Further Analysis of Clinical Isolates of E. coli Since the
According to the criteria proposed by Tenover et al. [8] , the Pseudooutbreak patterns in lanes 3 and 5 were possibly related to that in lane 1, and those in lanes 4 and 6 were unrelated to that in lane 2.
Because all the E. coli strains causing this outbreak were uniformly resistant to ciprofloxacin, we investigated the cause To complement and clarify the epidemiological relationship, we also performed plasmid typing. The plasmid profiles were and pattern of quinolone resistance in more clinical isolates of / 9c40$$de13 11-11-97 17:19:02 cidal UC: CID In addition to this mutational change, there was one more to guanosine at nucleotide 260), and histidine (Asp87His; guanosine to cytidine at nucleotide 259). It is interesting that the MICs for the strains with the same mutation pattern were differ-E. coli. From October 1994 to September 1995, we collected ent from each other (table 3) . 36 more E. coli isolates from blood. All but one of the isolates were resistant to ciprofloxacin. FIGE patterns of all the resistant isolates had a difference of more than seven bands. Cluster Discussion analysis with a dendrogram of these strains revealed that each
The antibiograms and genotypic patterns revealed little evistrain was not clonally related (figure 3). Amplification and dence of clonal spread, which disproved our initial assumption restriction analysis with use of HinfI of the QRDR in these that the outbreak might have originated from a single clone. isolates revealed two bands, while analysis of a wild-type strain Although some isolates' genotypic patterns revealed by FIGE showed three bands (figure 4), which indicated that there were showed a possible relation with the outbreak pattern, those alterations of the HinfI restriction site on the QRDR. SSCP isolates turned out to be different according to the plasmid analysis revealed various mobility patterns (figure 5).
profiles. As a result, we concluded that the outbreak of E. coli According to cluster analysis, there were 10 types of mobility bacteremia was at least not due to person-to-person transmispatterns (figure 6), which suggested that there had been various sion. conformational changes in the QRDR in gyrA that were possiAlthough surveillance cultures of specimens from patients bly induced by at least one point mutation in that area. After were negative, we thought that the strains might have been selecting representative strains on the basis of SSCP patterns, part of a patient's own flora, such as that of the gastrointestinal we performed sequencing on the QRDR in gyrA. Nucleotide tract. More important, we found that all the isolates had a sequencing on the QRDR in gyrA revealed a transition (cytidine common feature of quinolone resistance. All the patients with to thymidine) at nucleotide 248 in all strains, thus leading to bacteremia received ciprofloxacin prophylactically for selective the substitution of leucine for serine at position 83 (Ser83Leu).
decontamination of the gastrointestinal tract, which suggested the possible cause of this unique pattern of quinolone resistance. Although there was no obvious proof of this postulation that some mutation had developed in gyrA. Further testing by SSCP analysis revealed that the mobility patterns varied and were different than that of the wild-type strain.
As a final step, we performed nucleotide sequencing of the QRDR in gyrA. There were four types of double mutation. Most strains had a Ser83Leu and Asp87Asn mutation, while others had different changes at deduced amino acid position 87 (Asp87Tyr, Asp87Gly, and Asp87His). The focus of interest was that the MICs for the strains with the same mutation pattern were different from each other. Because it was reported that one single mutation in gyrA could lead to a change of 0.25 mg/mL in the MIC [12] , we thought that another resistance mechanism, such as active efflux or a mutation in parC [13 -15] , had contributed to the increase in the MIC in addition to the mutation in gyrA. In summary, there was no crosstransmission of a quinolone-resistant clone, and a double mutation on the QRDR in gyrA was the primary mechanism of Although we could not elucidate the reason for the selection effect on and the predominance of these strains of quinoloneHence, we retrospectively examined the microbiological reports from 1992 to 1995. There was a high incidence of bacteremia due to quinolone-resistant E. coli in patients with hematologic malignancy (range, 81.8% -94.6%). This phenomenon made us perform further analysis, and we collected additional isolates of E. coli from this pseudooutbreak. As FIGE showed, there also was no clonal relationship between these other isolates.
We further analyzed the resistance mechanisms of these strains. We amplified gyrA and analyzed RFLP patterns with NOTE. Asn Å asparagine; Asp Å aspartic acid; Gly Å glycine; His Å histidine; Leu Å leucine; Ser Å serine; Tyr Å tyrosine.
causing little derangement of anaerobic bowel flora [2] ). We believe that it is tentatively acceptable to continue prophylaxis with this drug; there are two reasons for our opinion. First, most of the strains of quinolone-resistant E. coli in our hospital were susceptible to empirical antimicrobial agents (such as third-generation cephalosporins, carbapenem, and monobactam). As the resistance patterns showed, the management of infectious diseases in granulocytopenic patients with hematologic malignancy was not impeded. Second, because most gram-negative bacilli other than E. coli are usually susceptible to quinolones, quinolone prophylaxis may still be effective for the eradication of potential gram-negative pathogens from the gut flora.
Since strains of quinolone-resistant E. coli are a potential threat in the future, however [4, 5] , we must pay attention to this new trend of resistance and restrict the use of quinolones to more strictly selected cases. In addition, we should weigh and reappraise the benefit of a selective decontamination regimen including quinolones through further prospective study.
